Xerostomia Therapeutics Global Market Report 2024

Description

Xerostomia therapeutics encompass treatments and medications utilized to manage dry mouth, a condition characterized by reduced saliva production. These therapies aim to alleviate symptoms such as difficulty swallowing and tasting, as well as prevent dental issues.

The main types of xerostomia therapeutics include artificial saliva or saliva substitutes, and salivary stimulants. Artificial saliva or saliva substitutes are products specifically formulated to replicate the natural properties of saliva, providing lubrication, moisture, and protection to the oral tissues. They are distributed through various channels including hospital pharmacies, retail pharmacies, drug stores, mail order pharmacies, as well as hypermarkets and supermarkets, catering to both adult and pediatric end users.

The xerostomia therapeutics market research report is one of a series of new reports from The Business Research Company that provides xerostomia therapeutics market statistics, including xerostomia therapeutics industry global market size, regional shares, competitors with a xerostomia therapeutics market share, detailed xerostomia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the xerostomia therapeutics industry. This xerostomia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The xerostomia therapeutics market size has grown strongly in recent years. It will grow from $2.04 billion in 2023 to $2.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth observed during the historic period can be attributed to several factors, including increasing incidences of xerostomia in the geriatric population, research and development of efficient products for xerostomia, growing awareness about xerostomia-related products, the increasing prevalence of medical conditions, and the rising prevalence of chronic diseases.

The xerostomia therapeutics market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 5.4%. The anticipated growth in the forecast period can be attributed to several factors, including the easy availability of cost-effective medications in the market, increased prevalence of oral health conditions, rising awareness among healthcare practitioners, government initiatives, and increased medication use. Major trends expected in the forecast period include the emergence of artificial saliva and saliva substitutes, technological advancements and product innovations, the adoption of personalized medicine and targeted therapies, the expansion of telehealth and remote monitoring, and the rise of non-invasive therapies.

The increasing utilization of chemotherapy in cancer care is anticipated to drive the expansion of the xerostomia therapeutics market in the future. Chemotherapy, a cornerstone of cancer treatment, employs potent medications to target and suppress the proliferation of cancer cells, contributing significantly to improved patient outcomes. Xerostomia therapeutics encompass various interventions such as saliva-stimulating medications and mouth rinses designed to alleviate dry mouth symptoms, enhance saliva production, and improve taste sensation, thereby facilitating proper nutrition and oral comfort for patients undergoing cancer treatment. For example, as of January 2022, the National Cancer Institute reported an estimated 18.1 million cancer survivors in the United States, constituting 5.4% of the total population. By 2032, this number is projected to reach 22.5 million worldwide, reflecting a 24.4% increase from current estimates. Hence, the rising adoption of chemotherapy in cancer management is a key driver behind the growth of the xerostomia therapeutics market.

Prominent companies operating in the xerostomia therapeutics sector are actively engaged in the development of saliva substitutes that emulate the natural properties of saliva, offering relief to individuals experiencing xerostomia. These substitutes effectively mitigate dry mouth discomfort by providing moisture, lubrication, pH balance, and cleansing to the oral cavity, ultimately promoting better oral health and enhanced quality of life. For instance, in September 2021, ICPA Health Products, a pharmaceutical firm based in India, introduced Wet Mouth, a saliva substitute formulated with advanced mouth moisturizing technology. Wet Mouth offers relief from dry mouth symptoms for up to four hours, maintaining oral pH balance without alcohol or sugar content, while also serving as a refreshing peppermint-flavored mouthwash and breath freshener.

In June 2022, Eagle Pharmaceuticals Inc., a US-based pharmaceutical company, completed the acquisition of Acacia Pharma Group plc for $104 million. This strategic move positions Eagle Pharmaceuticals as a significant player in the xerostomia therapeutics market, enhancing its product portfolio, market access, research and development capabilities, and potential for synergies and operational efficiencies. Acacia Pharma Group plc, headquartered in the UK, specializes in the development and commercialization of products aimed at addressing xerostomia and related conditions.

Major companies operating in the xerostomia therapeutics market are Bayer AG, 3M Company, GlaxoSmithKline plc, Colgate-Palmolive Company, Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Church & Dwight Co. Inc., Cipla Ltd., Hikma Pharmaceuticals PLC, Lupin Limited, Synedgen Inc., Sunstar Suisse S.A., Advanz Pharma Corp., Pharmascience Inc., Mission Pharmacal Company, Dentaid Ltd., Cyclacel Pharmaceuticals Inc., Parnell Pharmaceuticals Holdings Ltd., Teva Pharmaceutical Industries Ltd., Forward Science Holding Inc., ICPA Health Products Ltd., CCMed Ltd., Bio Cosmetics Laboratories S.L., Quest Products LLC, Acacia Pharma, Saliwell Limited, OraCoat, Oralieve UK Ltd., OraPharma Inc., OraVital Inc

North America was the largest region in the xerostomia therapeutics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the xerostomia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the xerostomia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The xerostomia therapeutics market consists of revenues earned by entities by providing services such as medical consultations, pharmacological assistance, dental care, patient education, support services, and research and development, all geared towards treating and managing dry mouth. The market value includes the value of related goods sold by the service provider or included within the service offering. The xerostomia therapeutics market also includes sales of oral moisturizers, dental products such as fluoride treatments and saliva-stimulating mouthwashes, and oral lubricants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Xerostomia Therapeutics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on xerostomia therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for xerostomia therapeutics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The xerostomia therapeutics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Artificial Saliva Or Saliva Substitutes; Salivary Stimulants
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Drug Stores; Mail Order Pharmacies; Hypermarkets And Supermarkets
3) By End-User: Adult; Pediatric
Companies Mentioned: Bayer AG; 3M Company; GlaxoSmithKline plc; Colgate-Palmolive Company; Fresenius Kabi AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18266

1. Executive Summary

2. Xerostomia Therapeutics Market Characteristics

3. Xerostomia Therapeutics Market Trends And Strategies

4. Xerostomia Therapeutics Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Xerostomia Therapeutics Market Size and Growth

5.1. Global Xerostomia Therapeutics Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Xerostomia Therapeutics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Xerostomia Therapeutics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Xerostomia Therapeutics Market Segmentation

6.1. Global Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Artificial Saliva Or Saliva Substitutes
Salivary Stimulants
6.2. Global Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Hypermarkets And Supermarkets
6.3. Global Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Adult
Pediatric

7. Xerostomia Therapeutics Market Regional And Country Analysis

7.1. Global Xerostomia Therapeutics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Xerostomia Therapeutics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Xerostomia Therapeutics Market

8.1. Asia-Pacific Xerostomia Therapeutics Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Xerostomia Therapeutics Market

9.1. China Xerostomia Therapeutics Market Overview
9.2. China Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Xerostomia Therapeutics Market

10.1. India Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Xerostomia Therapeutics Market

11.1. Japan Xerostomia Therapeutics Market Overview
11.2. Japan Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Xerostomia Therapeutics Market

12.1. Australia Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Xerostomia Therapeutics Market

13.1. Indonesia Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Xerostomia Therapeutics Market

14.1. South Korea Xerostomia Therapeutics Market Overview
14.2. South Korea Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Xerostomia Therapeutics Market

15.1. Western Europe Xerostomia Therapeutics Market Overview
15.2. Western Europe Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Xerostomia Therapeutics Market

16.1. UK Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Xerostomia Therapeutics Market

17.1. Germany Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Xerostomia Therapeutics Market

18.1. France Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Xerostomia Therapeutics Market

19.1. Italy Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Xerostomia Therapeutics Market

20.1. Spain Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Xerostomia Therapeutics Market

21.1. Eastern Europe Xerostomia Therapeutics Market Overview
21.2. Eastern Europe Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Xerostomia Therapeutics Market

22.1. Russia Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Xerostomia Therapeutics Market

23.1. North America Xerostomia Therapeutics Market Overview
23.2. North America Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Xerostomia Therapeutics Market

24.1. USA Xerostomia Therapeutics Market Overview
24.2. USA Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Xerostomia Therapeutics Market

25.1. Canada Xerostomia Therapeutics Market Overview
25.2. Canada Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Xerostomia Therapeutics Market

26.1. South America Xerostomia Therapeutics Market Overview
26.2. South America Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Xerostomia Therapeutics Market

27.1. Brazil Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Xerostomia Therapeutics Market

28.1. Middle East Xerostomia Therapeutics Market Overview
28.2. Middle East Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Xerostomia Therapeutics Market

29.1. Africa Xerostomia Therapeutics Market Overview
29.2. Africa Xerostomia Therapeutics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Xerostomia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Xerostomia Therapeutics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Xerostomia Therapeutics Market Competitive Landscape And Company Profiles

30.1. Xerostomia Therapeutics Market Competitive Landscape
30.2. Xerostomia Therapeutics Market Company Profiles
- 30.2.1. Bayer AG
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. 3M Company
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. GlaxoSmithKline plc
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Colgate-Palmolive Company
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Fresenius Kabi AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Xerostomia Therapeutics Market Other Major And Innovative Companies

31.1. Sun Pharmaceutical Industries Ltd.
31.2. Church & Dwight Co. Inc.
31.3. Cipla Ltd.
31.4. Hikma Pharmaceuticals PLC
31.5. Lupin Limited
31.6. Synedgen Inc.
31.7. Sunstar Suisse S.A.
31.8. Advanz Pharma Corp.
31.9. Pharmascience Inc.
31.10. Mission Pharmacal Company
31.11. Dentaid Ltd.
31.12. Cyclacel Pharmaceuticals Inc.
31.13. Parnell Pharmaceuticals Holdings Ltd.
31.14. Teva Pharmaceutical Industries Ltd.
31.15. Forward Science Holding Inc.

32. Global Xerostomia Therapeutics Market Competitive Benchmarking

33. Global Xerostomia Therapeutics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Xerostomia Therapeutics Market

35. Xerostomia Therapeutics Market Future Outlook and Potential Analysis

35.1 Xerostomia Therapeutics Market In 2028 - Countries Offering Most New Opportunities
35.2 Xerostomia Therapeutics Market In 2028 - Segments Offering Most New Opportunities
35.3 Xerostomia Therapeutics Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer